Example: Heart Attack

Search clinical trials for: Bismuth tripotassium dicitrate

Total 94 results

NCT04401020

Not yet recruiting

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Conditions: Neoplasm Malignant
NCT04397445

Active, not recruiting

Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration

Conditions: Ranitidine Adverse Reaction; Pharmacokinetics; Food-drug Interaction
NCT04359966

Not yet recruiting

Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia

Conditions: Helicobacter Pylori Infection; Eradication Treatments
NCT04264663

Recruiting

Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin

Conditions: Helicobacter Pylori Infection
NCT04122287

Recruiting

Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin

Conditions: Helicobacter Pylori Infection
NCT04107194

Not yet recruiting

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

Conditions: Helicobacter Pylori Infection; Antibiotic Resistant Infection; Antibiotic Resistant Strain
NCT04101708

Not yet recruiting

A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients

Conditions: Helicobacter Pylori
NCT04066257

Completed

Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers

Conditions: Healthy
NCT03968302

Completed

ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION

Conditions: Helicobacter Pylori Infection
NCT03925818

Terminated

Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication

Conditions: Helicobacter Pylori Infection
NCT03897244

Recruiting

Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication

Conditions: Helicobacter Pylori Infection
NCT03779074

Recruiting

Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies

Conditions: Helicobacter Pylori Infection
NCT03779087

Recruiting

Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection

Conditions: Helicobacter Pylori Infection
NCT03716622

Completed

A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication

Conditions: Helicobacter Pylori
NCT03583567

Recruiting

Effect of Anti-histamine in Prevention Systolic Hypotension After Protamine

Conditions: Protamine Adverse Reaction
NCT03468777

Terminated

A Crossover Study to Assess the Drug-drug Interaction of Acid Reducing Agent(s) on the Pharmacokinetics of a Single Oral Dose of Lumicitabine (JNJ-64041575) in Healthy Adult Participants

Conditions: Healthy
NCT03365609

Recruiting

A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children

Conditions: Helicobacter Infections
NCT03321773

Recruiting

Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth Therapy

Conditions: Helicobacter Pylori Infection
NCT03319667

Active, not recruiting

Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant

Conditions: Plasma Cell Myeloma
NCT03145012

Active, not recruiting

Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity

Conditions: Cancer
NCT03146325

Withdrawn

Helicobacter Pylori and Body Iron in Adults

Conditions: Helicobacter Pylori Infection
NCT03140033

Unknown status

Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery

Conditions: Hemorrhage Postpartum
NCT03108287

Completed

Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori

Conditions: Helicobacter Pylori Infection
NCT03050359

Completed

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection

Conditions: Duodenal Ulcer
NCT03011463

Completed

Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for OCT1

Conditions: Pharmacokinetics; Inhibition Enzyme; Drug Interaction Potentiation
NCT02999633

Terminated

Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia

Conditions: T-cell Type Acute Leukemia-Precursor; T-lymphoblastic Lymphoma/Leukaemia
NCT02953210

Unknown status

Laparoscopic Cholecystectomy: General Anesthesia With Opioid Versus General Opioid Free Anesthesia

Conditions: Pain, Postoperative; Anesthesia Complication; Nausea; Vomiting; Ileus Paralytic; Hemodynamic Instability
NCT02894268

Recruiting

Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy

Conditions: Helicobacter Pylori Infection
NCT02788123

Terminated

A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy

Conditions: NSAID-induced Gastropathy
NCT02733640

Completed

Does Pantoprazole Reduce the Anti-platelet Effect of Clopidogrel?

Conditions: Antiplatelet Effect
NCT02700087

Withdrawn

In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?

Conditions: Laryngomalacia; Acid Reflux; Stridor
NCT02682446

Completed

The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm

Conditions: Gastric Cancer
NCT02555852

Completed

Proton Pump Inhibitors and Risk of Community-acquired Pneumonia

Conditions: Gastroesophageal Reflux Disease (GERD); Community-acquired Pneumonia
NCT02547025

Recruiting

Personalized Treatment for Refractory H Pylori Infection

Conditions: Helicobacter Pylori Infection
NCT02547038

Completed

Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy

Conditions: Helicobacter Pylori Infection
NCT02541864

Completed

Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication

Conditions: Helicobacter Pylori Infection
NCT02490839

Completed

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection

Conditions: Helicobacter Pylori Infection
NCT02483715

Completed

Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection

Conditions: Helicobacter Pylori Infection
NCT02441673

Unknown status

Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering

Conditions: Post Anaesthetic Shivering
NCT02373280

Recruiting

The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection

Conditions: Helicobacter Infection
NCT02359331

Recruiting

The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection

Conditions: Helicobacter Infection
NCT02349685

Completed

The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori

Conditions: Helicobacter Infection
NCT02197143

Completed

A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain

Conditions: Dyspepsia
NCT02195804

Completed

Bioavailability Study of Ranitidine Hydrochloride (Maximum Strength ZANTAC 150®) Compared to Two Different 150 mg Ranitidine Hydrochloride Oral Disintegrating Tablet (ODT) in Fasting, Healthy Male Volunteers

Conditions: Healthy
NCT02172417

Completed

Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female Subjects

Conditions: Healthy
NCT02170792

Completed

Bioavailability of BIBR 953 ZW After Dose of BIBR 1048 MS

Conditions: Healthy
NCT02123498

Withdrawn

The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux

Conditions: Eustachian Tube Dysfunction; Laryngopharyngeal Reflux
NCT02004197

Completed

Quadruple and Phytomedicine-based Therapies in H. Pylori Infection

Conditions: Helicobacter Pylori [H. Pylori] as the Cause of Diseases
NCT01976078

Completed

Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents

Conditions: Pharmacokinetics; Voriconazole
NCT01908257

Completed

Lesinurad Interaction Study With Ranitidine

Conditions: Healthy